Novel findings with dual SGLT1 and SGLT2 inhibitor in diabetes patients - PACE-CME

Novel findings with dual SGLT and SGLT inhibitor in diabetes patients

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Comparing P2Y12 inhibitors in patients undergoing elective PCI
Comparing P2Y12 inhibitors in patients undergoing elective PCI
AHA 2020
Comparing P2Y12 inhibitors in patients undergoing elective PCI
- Jur ten Berg, MD, PhD
Results of omega-3 fatty acids trials may not be contradictory
Results of omega-3 fatty acids trials may not be contradictory
AHA 2020
Results of omega-3 fatty acids trials may not be contradictory
- Deepak Bhatt, MD
Side effects in a trial with statin, placebo and tablet-free periods
Side effects in a trial with statin, placebo and tablet-free periods
AHA 2020
Side effects in a trial with statin, placebo and tablet-free periods
- Prof. Darrel Francis, MD
No effect of omega-3 carboxylic acid on MACE in high-risk patients
No effect of omega-3 carboxylic acid on MACE in high-risk patients
AHA 2020
No effect of omega-3 carboxylic acid on MACE in high-risk patients
- Prof. Michael Lincoff, MD